TEVA
Teva Pharma Industries Ltd
36.50$
-0.6%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 45.5% | 42.2% | 45.9% | 51.6% | 56.0% | 55.4% | 53.6% | 52.2% | 53.3% | 51.8% | 51.3% | 48.2% | |
| 54.5% | 57.8% | 54.1% | 48.4% | 44.0% | 44.6% | 46.4% | 47.8% | 46.7% | 48.2% | 48.7% | 51.8% | |
| 7.3% | 7.8% | 9.6% | 8.3% | 6.4% | 6.0% | 10.8% | 6.9% | 5.6% | 6.0% | 6.4% | 5.9% | |
| 6.0% | 6.3% | 5.6% | 5.9% | 6.9% | 7.1% | 7.0% | 6.9% | 7.9% | 7.3% | 7.0% | 7.5% | |
| 32.4% | 31.8% | 32.9% | 30.5% | 28.8% | 47.2% | 67.8% | 37.0% | 61.4% | 28.1% | 50.6% | 39.3% | |
| 19.5% | 17.1% | 9.8% | -78.1% | -8.7% | -2.6% | -21.4% | 10.8% | -14.7% | 2.7% | -1.8% | 12.5% | |
| 1.4% | 2.4% | 6.1% | 4.0% | 4.7% | 5.7% | 4.5% | 5.6% | 6.2% | 6.5% | 5.7% | 5.3% | |
| 17.9% | 12.0% | 3.8% | -82.1% | -13.8% | -4.3% | -23.6% | 4.2% | -21.1% | -3.9% | -7.8% | 7.2% | |
| 2.9% | 3.2% | 2.4% | -8.6% | -1.0% | 1.6% | 1.0% | 1.3% | -4.3% | -0.4% | 4.1% | -1.0% | |
| 15.1% | 8.1% | 1.5% | -72.7% | -11.4% | -5.9% | -24.0% | 2.6% | -16.4% | -3.5% | -9.9% | 8.2% | |
| 29.5% | 32.3% | 13.1% | -69.3% | 1.0% | 26.3% | 27.7% | 27.8% | -6.2% | 2.7% | 26.8% | 18.2% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.